The 1st World Congress on Controversies in Hematology (COHEM) Rome, Italy, 2-5 September, 2010
Novartis Satellite Symposium
CURRENT PROGRESS IN CML THERAPY Friday, September 3, 2010 13:15 - 14:30, Hall A   Chairpersons: M. Baccarani, Italy R. Hehlmann, Germany 13:15-13:20 Welcome 13:20-13:35 Molecular Monitoring of CML: Progress in standardization F. Pane, Italy 13:35-13:45 Discussion 13:45-14:00 Second generation TKIs as first-line therapy: ENESTnd A. Hochhaus, Germany 14:00-14:10 Discussion 14:10-14:25 Nilotinib: A selective choice for resistant and Intolerant patients to Imatinib M. Breccia, Italy 14:25-14:30 Closing